Anti‐idiotypic antibodies and regulation of immune responses
1992; Wiley; Volume: 32; Issue: 4 Linguagem: Inglês
10.1046/j.1537-2995.1992.32492263453.x
ISSN1537-2995
Autores Tópico(s)T-cell and B-cell Immunology
ResumoTransfusionVolume 32, Issue 4 p. 361-376 Anti-idiotypic antibodies and regulation of immune responses G.E. RODEY MD, Corresponding Author G.E. RODEY MD Professor1Department of Pathology, Emory University School of Medicine, Winship Cancer Center, Rm 5207, 1327 Clifton Road, NE, Atlanta, GA 30322.Search for more papers by this author G.E. RODEY MD, Corresponding Author G.E. RODEY MD Professor1Department of Pathology, Emory University School of Medicine, Winship Cancer Center, Rm 5207, 1327 Clifton Road, NE, Atlanta, GA 30322.Search for more papers by this author First published: May 1992 https://doi.org/10.1046/j.1537-2995.1992.32492263453.xCitations: 12Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Von Boehmer H. The developmental biology of T lymphocytes. Annu Rev Immunol 1988; 6: 309–26. 2 Hedrick SM. T lymphocyte receptors. In: WE Paul, ed. Fundamental immunology. 2nd ed. New York: Raven Press, 1989: 291–313. 3 Max EE. Immunoglobulins: molecular genetics. In: WE Paul, ed. Fundamental immunology. 2nd ed. New York: Raven Press, 1989: 235–90. 4 Dorf ME, Benacerraf B. Suppressor cells and immunoregulation. Annu Rev Immunol 1984; 2: 127–57. 5 Asherson GL, Colizzi V, Zembola M. An overview of T-suppressor cell circuits. Annu Rev Immunol 1986; 4: 37–68. 6 Hodes RJ. T-cell-mediated regulation: help and suppression. In: WE Paul, ed. Fundamental immunology. 2nd ed. New York: Raven Press, 1989: 587–620. 7 Male D, Champion B, Cooke A. Advanced immunology. Philadelphia: JB Lippincott, 1987; 10. 1–10.18. 8 Rajewsky K, Takemori T. Genetics, expression, and function of idiotypes. Annu Rev Immunol 1983; 1: 569–607. 9 Davie JM, Seiden MV, Greenspan NS, Lutz CT, Bartholow TL, Clevinger BL. Structural correlates of idiotopes. Annu Rev Immunol 1986; 4: 147–65. 10 Schrater AF, Goidl EA, Thorbecke GJ, Siskind GW. Production of auto-anti-idiotypic antibody during the normal immune response to TNP-ficoll. I. Occurrence in AKR/J and BALB/c mice of hapten-augmentable, anti-TNP plaque-forming cells and their accelerated appearance in recipients of immune spleen cells. J Exp Med 1979; 150: 138–53. 11 Kelsoe G, Cerny J. Reciprocal expansions of idiotypic and anti-idiotypic clones following antigen stimulation. Nature 1979; 279: 333–4. 12 Geha RS. Presence of auto-anti-idiotypic antibody during the normal human immune response to tetanus toxoid antigen. J Immunol 1982; 129: 139–44. 13 Langman RE. The immune system. San Diego: Academic Press, 1989. 14 Jerne NK. Towards a network theory of the immune system. Ann Immunol (Paris) 1974; 125C: 373–89. 15 Richter PH. A network theory of the immune system. Eur J Immunol 1975; 5: 350–4. 16 Paul WE, Bona C. Regulatory idiotopes and immune networks: a hypothesis. Immunol Today 1982; 3: 230–4. 17 Kearney JF. Idiotypic networks. In: WE Paul, ed. Fundamental immunology. 2nd ed. New York: Raven Press, 1989: 663–76. 18 Pereira P, Bandeira A, Coutinho A, Marcos MA, Toribio M, Martinez AC. V-region connectivity in T cell repertoires. Annu Rev Immunol 1989; 7: 209–49. 19 Raulet DH. The structure, function, and molecular genetics of the γ/8 T cell receptor. Annu Rev Immunol 1989; 7: 175–207. 20 Forre O, Natvig JB, Michaelsen TE. Cross-idiotypic reactions among anti-Rh (D) antibodies. Scand J Immunol 1977; 6: 997–1003. 21 Kennedy RC, Dreesman GR. Common idiotypic determinant associated with human antibodies to hepatitis B surface antigen. J Immunol 1983; 130: 385–9. 22 Bose R, Marsh DG, Duchateau J, Sehon AH, Delespesse G. Demonstration of auto-anti-idiotypic antibody cross-reacting with public idiotypic determinants in the serum of rye-sensitive allergic patients. J Immunol 1984; 133: 2474–8. 23 Hoebeke J, Vauquelin G, Strosberg AD. The production and characterization of antibodies against β-adrenergic antagonists. Biochem Pharmacol 1977; 27: 1527–32. 24 Sege K, Peterson PA. Use of anti-idiotypic antibodies as cell-surface receptor probes. Proc Natl Acad Sci U S A 1978; 75: 2443–7. 25 Wassermann NH, Penn AS, Freimuth PI, et al. Anti-idiotypic route to anti-acetylcholine receptor antibodies and experimental myasthenia gravis. Proc Natl Acad Sci U S A 1982; 79: 4810–4. 26 Schechter Y, Elias I, Maron R, Cohen IR. Mouse antibodies to the insulin receptor developing spontaneously as anti-idiotypes. I. Characterization of the antibodies. J Biol Chem 1984; 259: 6411–5. 27 Roy BF, Bowen WD, Frazier JS, et al. Human antiidiotypic antibody against opiate receptors. Ann Neurol 1988; 24: 57–63. 28 Hasemann CA, Capra JD. Immunoglobulins: structure and function. In: WE Paul, ed. Fundamental immunology. 2nd ed. New York: Raven Press, 1989: 209–33. 29 Edmundson AB, Ely KR, Herron JN. A search for site-filling ligands in the Mcg Bence-Jones dimer: crystal binding studies of fluorescent compounds. Mol Immunol 1984; 21: 561–76. 30 Amit AG, Mariuzza RA, Phillips SE, Poljak RJ. Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution. Science 1986; 233: 747–53. 31 Colman PM, Laver WG, Varghese JN, et al. Three-dimensional structure of a complex of antibody with influenza virus neuraminidase. Nature 1987; 326: 358–63. 32 Roitt IM, Thanavala YM, Male DK, Hay FC. Anti-idiotypes are surrogate antigens: structural considerations. Immunol Today 1985; 6: 265–7. 33 Oudin J, Michel M. [A new allotype form of rabit serum 7-globulins, apparently associated with antibody function and specificity]. C R Acad Sci (Paris) 1963; 257: 805–8. 34 Kunkel HG, Mannik M, Williams RC. Individual antigenic specificity of isolated antibodies. Science 1963; 140: 1218–9. 35 Eichmann K, Rajewsky K. Induction of T and B cell immunity by anti-idiotypic antibody. Eur J Immunol 1975; 5: 661–6. 36 Woodland R, Cantor H. Idiotype-specific T helper cells are required to induce idiotype-positive B memory cells to secrete antibody. Eur J Immunol 1978; 8: 600–6. 37 Bona C, Paul WE. Cellular basis of regulation of expression of idiotype. I. T-suppressor cells specific for MOPC 460 idiotype regulate the expression of cells secreting anti-TNP antibodies bearing 460 idiotype. J Exp Med 1979; 149: 592–600. 38 Cerny J, Caulfield MJ. Stimulation of specific antibody-forming cells in antigen-primed nude mice by the adoptive transfer of syngeneic anti-idiotypic T cells. J Immunol 1981; 126: 2262–6. 39 Geha RS, Weinberg RP. Anti-idiotypic antisera in man. I. Production and immunochemical characterization of anti-idiotypic anti-sera to human antitetanus antibodies. J Immunol 1978; 121: 1518–23. 40 Geha RS. Presence of circulating anti-idiotype-bearing cells after booster immunization with tetanus toxoid (TT) and inhibition of anti-TT antibody synthesis by auto-anti-idiotypic antibody. J Immunol 1983; 130: 1634–9. 41 Hart DA, Wang AL, Pawlak LL, Nisonoff A. Suppression of idiotypic specificities in adult mice by administration of antiidiotypic antibody. J Exp Med 1972; 135: 1293–300. 42 Zouali M, Eyquem A. Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillating levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient. Ann Immunol (Paris) 1983; 134C: 377–91. 43 Zanetti M, Glotz D, Rogers J. Perturbation of the autoimmune network. II. Immunization with isologous idiotype induces auto-anti-idiotypic antibodies and suppresses the autoantibody response elicited by antigen: a serologic and cellular analysis. J Immunol 1986; 137: 3140–6. 44 Nossal GJ. Cellular mechanisms of immunologic tolerance. Annu Rev Immunol 1983; 1: 33–62. 45 Nemazee DA, Sato VL. Induction of rheumatoid antibodies in the mouse Regulated production of autoantibody in the secondary humoral response. J Exp Med 1983; 158: 529–45. 46 Cohen IR, Cooke A. Natural antibodies might prevent autoimmune disease. Immunol Today 1986; 7: 363–4. 47 Carson DA, Chen PP, Fox RI, et al. Rheumatoid factor and immune networks. Annu Rev Immunol 1987; 5: 109–26. 48 Dighiero G, Lymberi P, Mazie JC, et al. Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens. J Immunol 1983; 131: 2267–72. 49 Dighiero G, Lymberi P, Holmberg D, Lundquist I, Coutinho A, Avrameas S. High frequency of natural autoantibodies in normal newborn mice. J Immunol 1985; 134: 765–71. 50 Casali P, Notkins AL. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol 1989; 7: 513–35. 51 Sanz I, Casali P, Thomas JW, Notkins AL, Capra JD. Nucleotide sequences of eight human natural autoantibody VH regions reveals apparent restricted use of VH families. J Immunol 1989; 142: 4054–61. 52 Welch MJ, Fong S, Vaughan J, Carson D. Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol 1983; 51: 299–304. 53 Holmberg D. High connectivity, natural antibodies preferentially use 7183 and QUPC 52 VH families. Eur J Immunol 1987; 17: 399–403. 54 Burastero SE, Casali P, Wilder RL, Notkins AL. Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis. J Exp Med 1988; 168: 1979–92. 55 Casali P, Notkins AL. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire. Immunol Today 1989; 10: 364–8. 56 Abdou NI, Wall H, Lindsley HB, Halsey JF, Suzuki T. Network theory in autoimmunity. In vitro suppression of serum anti-DNA antibody binding to DNA by anti-idiotypic antibody in systemic lupus erythematosus. J Clin Invest 1981; 67: 1297–304. 57 Taniguchi O, Chia DS, Barnett EV. Auto-anti-anti-DNA antibodies from SLE patients and normals. J Rheumatol 1984; 11: 291–7. 58 Puccetti A, Migliorini P, Sabbaga J, Madaio MP. Human and murine anti-DNA antibodies induce the production of anti-idiotypic antibodies with autoantigen-binding properties (epibodies) through immune-network interactions. J Immunol 1990; 145: 4229–37. 59 Horsfall AC, Mumford PA, Venables PJ, Maini RN. Anti-idiotypic induced suppression of Sjogren's syndrome associated anti-La autoantibody secretion in vitro. Clin Exp Immunol 1988; 71: 62–6. 60 Heimer R, Wolfe LD, Abruzzo JL. IgM and IgG anti-F(ab′)2 antibodies in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1298–306. 61 Searles RP, Savage SM, Brozek CM, Marnell LL, Hoffman CL. Network regulation in rheumatoid arthritis. Studies of DR+ T cells, anti-DR, antiidiotypic antibodies, and clinical disease activity Arthritis Rheum 1988; 31: 834–43. 62 Moore TL, Osborn TG, Dorner RW. Cross-reactive antiidiotypic antibodies against human rheumatoid factors from patients with juvenile rheumatoid arthritis. Arthritis Rheum 1989; 32: 699–705. 63 Geltner D, Franklin EC, Frangione B. Antiidiotypic activity in the IgM fractions of mixed cryoglobulins. J Immunol 1980; 125: 1530–5. 64 Geha RS, Quinti I, Austen KF, Cicardi M, Sheffer A, Rosen FS. Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. N Engl J Med 1985; 312: 534–40. 65 Goldman M, Rose LM, Hochmann A, Lambert PH. Deposition of idiotype-anti-idiotype immune complexes in renal glomeruli after polyclonal B cell activation. J Exp Med 1982; 155: 1385–99. 66 Zanetti M, Wilson CB. A role for antiidiotypic antibodies in immunologically mediated nephritis. Am J Kidney Dis 1986; 7: 445–51. 67 Dwyer DS, Bradley RJ, Urquhart CK, Kearney JF. Naturally occurring anti-idiotypic antibodies in myasthenia gravis patients. Nature 1983; 301: 611–4. 68 Cleveland WL, Wassermann NH, Sarangarajan R, Penn AS, Erlanger BF. Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism. Nature 1983; 305: 56–7. 69 Dwyer DS, Vakil M, Kearney JF. Idiotypic network connectivity and a possible cause of myasthenia gravis. J Exp Med 1986; 164: 1310–8. 70 Lefvert AK. The start of an autoimmune disease: idiotypic network during early progression of myasthenia gravis. Ann Inst Pasteur Immunol 1988; 139: 633–43. 71 Hall R, Smith BR, Mukhtar ED. Thyroid stimulators in health and disease. Clin Endocrinol (Oxf) 1975; 4: 213–30. 72 Zanetti M, Bigazzi PE. Anti-idiotypic immunity and autoimmunity. I. In vitro and in vivo effects of anti-idiotypic antibodies to spontaneously occurring autoantibodies to rat thyroglobulin. Eur J Immunol 1981; 11: 187–95. 73 Zouali M, Fine JM, Eyquem A. A human monoclonal IgG1 with anti-idiotypic activity against anti-human thyroglobulin autoantibody. J Immunol 1984; 133: 190–4. 74 Tachovsky TG, Sandberg-Wollheim M, Baird LG. Rabbit anti-human CSF IgG. I. Characterization of anti-idiotype antibodies produced against MS CSF and detection of cross-reactive idiotypes in several MS CSF. J Immunol 1982; 129: 764–70. 75 Lider O, Reshef T, Beraud E, Ben-Nun A, Cohen IR. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis. Science 1988; 239: 181–3. 76 Shoelson SE, Marshall S, Horikoshi H, Kolterman OG, Rubenstein AH, Olefsky JM. Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes. J Clin Endocrinol Metab 1986; 63: 56–61. 77 Schwartz RS, Datta SK. Autoimmunity and autoimmune diseases. In: WE Paul, ed. Fundamental immunology. 2nd ed. New York: Raven Press, 1989: 819–66. 78 Isenberg DA, Shoenfeld Y, Madaio MP, et al. Anti-DNA antibody idiotypes in systemic lupus erythematosus. Lancet 1984; 2: 417–22. 79 Hahn BH, Ebling FM. A public idiotypic determinant is present on spontaneous cationic IgG antibodies to DNA from mice of unrelated lupus-prone strains. J Immunol 1984; 133: 3015–9. 80 Eilat D, Fischel R, Zlotnick A. A central anti-DNA idiotype in human and murine systemic lupus erythematosus. Eur J Immunol 1985; 15: 368–75. 81 Shoenfeld Y, Ben-Yehuda O, Napartstek Y, et al. The detection of a common idiotype of anti-DNA antibodies in the sera of patients with monoclonal gammopathies. J Clin Immunol 1986; 6: 194–204. 82 Hoch S, Schwaber J. Identification and sequence of the VH gene elements encoding a human anti-DNA antibody. J Immunol 1987; 139: 1689–93. 83 Dersimonian H, Schwartz RS, Barrett KJ, Stollar BD. Relationship of human variable region heavy chain germ-line genes to genes encoding anti-DNA autoantibodies. J Immunol 1987; 139: 2496–501. 84 O'Keefe TL, Bandyopadhyay S, Datta SK, Imanishi-Kari T. V region sequences of an idiotypically connected family of pathogenic anti-DNA autoantibodies. J Immunol 1990; 144: 4275–83. 85 Cairns E, Kwong PC, Misener V, Ip P, Bell DA, Siminovitch KA. Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. Implications for the molecular basis of human autoimmune responses. J Immunol 1989; 143: 685–91. 86 Panosian-Sahakian N, Klotz JL, Ebling F, Kronenberg M, Hahn B. Diversity of Ig V gene segments found in anti-DNA autoantibodies from a single (NZB × NZW)F1 mouse. J Immunol 1989; 142: 4500–6. 87 Hahn B, Ebling F. Suppression of murine lupus nephritis by administration of an anti-idiotypic antibody to anti-DNA. J Immunol 1984; 132: 187–90. 88 Sasaki T, Muryoi T, Takai O, et al. Selective elimination of anti-DNA antibody-producing cells by antiidiotypic antibody conjugated with neocarzinostatin. J Clin Invest 1986; 77: 1382–6. 89 Kunkel HG, Winchester RJ, Joslin FG, Capra JD. Similarities in the light chains of anti-γ-globulins showing cross-idiotypic specificities. J Exp Med 1974; 139: 128–36. 90 Abraham GN, Podell DN, Welch EH, Johnston SL. Idiotypic relatedness of human monoclonal IgG cryoglobulins. Immunology 1983; 48: 315–20. 91 Carson DA, Fong S. A common idiotope on human rheumatoid factors identified by a hybridoma antibody. Mol Immunol 1983; 20: 1081–7. 92 Pons-Estel B, Goni F, Solomon A, Frangione B. Sequence similarities among κ IIIb chains of monoclonal human IgM &kapa; autoantibodies. J Exp Med 1984; 160: 893–904. 93 Chen PP, Goni F, Houghten RA, et al. Characterization of human rheumatoid factors with seven antiidiotypes induced by synthetic hypervariable region peptides. J Exp Med 1985; 162: 487–500. 94 Fong S, Chen PP, Gilbertson TA, Fox RI, Vaughan JH, Carson DA. Structural similarities in the kappa light chains of human rheumatoid factor paraproteins and serum immunoglobulins bearing a cross-reactive idiotype. J Immunol 1985; 135: 1955–60. 95 Ruiz-Arguelles A, Presno-Bernal M. Demonstration of a cross-reactive idiotype (IdRQ) in rheumatoid factors from patients with rheumatoid arthritis but not in rheumatoid factors from healthy, aged subjects. Arthritis Rheum 1989; 32: 134–8. 96 Imbach P, Barandun S, D'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981; 1: 1228–31. 97 Fehr J, Hofmann V, Kappeler U. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 1982; 306: 1254–8. 98 Bussel JB, Kimberly RP, Inman RD, et al. Intravenous gammaglobulin treatment of chronic idiopathic thrombocytopenic purpura. Blood 1983; 62: 480–6. 99 Newland AC, Treleaven JG, Minchinton RM, Waters AH. High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet 1983; 1: 84–7. 100 Delfraissy JF, Tchernia G, Laurian Y, Wallon C, Galanaud P, Dormont J. Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura. Br J Haematol 1985; 60: 315–22. 101 Dammacco F, Iodice G, Campobasso N. Treatment of adult patients with idiopathic thrombocytopenic purpura with intravenous immunoglobulin: effects on circulating T cell subsets and PWM-induced antibody synthesis in vitro. Br J Haematol 1986; 62: 125–35. 102 Bussel JB, Pham LC, Aledort L, Nachman R. Maintenance treatment of adults with chronic refractory immune thrombocytopenic purpura using repeated intravenous infusions of gammaglobulin. Blood 1988; 72: 121–7. 103 Berchtold P, Dale GL, Tani P, McMillan R. Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin. Blood 1989; 74: 2414–7. 104 Pollack S, Cunningham-Rundles C, Smithwick EM, Barandun S, Good RA. High-dose intravenous gamma globulin for autoimmune neutropenia (letter). N Engl J Med 1982; 307: 253. 105 Bussel J, Lalezari P, Hilgartner M, et al. Reversal of neutropenia with intravenous gammaglobulin in autoimmune neutropenia of infancy. Blood 1983; 62: 398–400. 106 McGuire WA, Yang HH, Bruno E, et al. Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin. N Engl J Med 1987; 317: 1004–8. 107 Macintyre EA, Linch DC, Macey MG, Newland AC. Successful response to intravenous immunoglobulin in autoimmune haemolytic anaemia. Br J Haematol 1985; 60: 387–8. 108 Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE. Antiidiotype suppression of autoantibodies to factor VIII (antihae-mophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984; 2: 765–8. 109 Rossi F, Sultan Y, Kazatchkine MD. Anti-idiotypes against autoantibodies and alloantibodies to VIII: C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins. Clin Exp Immunol 1988; 74: 311–6. 110 Zimmermann R, Kommerell B, Harenberg J, Eich W, Rother K, Schimps KL. Intravenous IgG for patients with spontaneous inhibitor to Factor VIII (letter). Lancet 1985; 1: 273–4. 111 Rossi F, Kazatchkine MD. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immunol 1989; 143: 4104–9. 112 McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL, Jr. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987; 70: 1040–5. 113 Sultan Y, Rossi F, Kazatchkine MD. Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies. Proc Natl Acad Sci U S A 1987; 84: 828–31. 114 Budde U, Auch D, Niese D, Schafer G, Reske SN, Schmidt RE. Reticuloendothelial system Fc-receptor function in patients with immune thrombocytopenia after treatment with high dose intravenous immunoglobulin. Scand J Haematol 1986; 37: 125–9. 115 Rohowsky C, Suciu-Foca N, Kung P, Tang TF, Reed E, King DW. Suppressor T cells in autologous MLR with MLC-activated T lymphoblasts. Transplant Proc 1983; 15: 765–70. 116 Suciu-Foca N, Reed E, Rohowsky C, Kung P, King DW. Antiidiotypic antibodies to anti-HLA receptors induced by pregnancy. Proc Natl Acad Sci U S A 1983; 80: 830–4. 117 Reed E, Hardy M, Benvenisty A, et al. Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients. N Engl J Med 1987; 316: 1450–5. 118 Braun WE, Klingman L, Stewart RW, et al. Two major serologic events in a successful cardiac transplant recipient—circumvention of hyperacute rejection despite a positive donor T lymphocyte crossmatch and late appearance of probable antiidiotypic antibody. Transplantation 1988; 46: 153–5. 119 Rodey GE, Phelan DL. Association of antiidiotypic antibody with successful second transplant of a kidney sharing HLA antigens with the previous hyperacutely rejected first kidney. Transplantation 1989; 48: 54–7. 120 Phelan DL, Rodey GE, Anderson CB. The development and specificity of antiidiotypic antibodies in renal transplant recipients recieving single-donor blood transfusions. Transplantation 1989; 48: 57–60. 121 Singal DP, Joseph S. Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients. Hum Immunol 1982; 4: 93–108. 122 Opelz G, Sengar DPS, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253–9. 123 Briggs JD, Canavan JS, Dick HM, Hamilton DM, Kyle KF, MacPherson SG. Influence of HLA matching and blood transfusion on renal allograft survival. Transplantation 1978; 25: 80–5. 124 Fehrman I, Groth CG, Lundgren G, Moller E. Improved renal graft survival in transfused uremics A result of a number of interacting factors. Transplantation 1980; 30: 324–7. 125 Opelz G, Graver B, Mickey MR, Terasaki PI. Lymphocytotoxic antibody responses to transfusions in potential kidney transplant recipients. Transplantation 1981; 32: 177–83. 126 Opelz G, Terasaki PI. International histocompatibility workshop study on renal transplantation. In: PI Terasaki, ed. Histocompatibility testing. Los Angeles: UCLA Typing Laboratories, 1980: 592–624. 127 Persijn GG, van Hooff JP, Kalff MW, Lansbergen Q, van Rood JJ. Effect of blood transfusions and HLA matching on renal transplantation in The Netherlands. Transplant Proc 1977; 9: 503–5. 128 Spees EK, Vaughn WK, Williams GM, et al. Effects of blood transfusion on cadaver renal transplantation: the Southeastern Organ Procurement Foundation prospective study (1977 to 1979). Transplantation 1980; 30: 455–63. 129 Anderson CB, Sicard GA, Rodey GE, Anderman CK, Etheredge EE. Renal allograft recipient pretreatment with donor-specific blood and concomitant immunosuppression. Transplant Proc 1983; 15: 939–42. 130 Salvatierra O Jr, Vincenti F, Amend W, et al. Deliberate donor-specific transfusions prior to living related renal transplantation A new approach. Ann Surg 1980; 192: 543–52. 131 Salvatierra O Jr, Vincenti F, Amend W Jr, et al. Four-year experience with donor-specific blood transfusions. Transplant Proc 1983; 15: 924–31. 132 Cecka M, Toyotome A. The transfusion effect. In: PI Terasaki, ed. Clinical transplants 1989. Los Angeles: UCLA Tissue Typing Laboratory, 1989: 335–41. 133 Lazda VA, Pollack R, Mozes MF, Barber PL, Jonasson O. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man. Transplantation 1990; 49: 1084–7. 134 Dorsch S, Roser R. Recirculating, suppressor T cells in transplantation tolerance. J Exp Med 1977; 145: 1144–57. 135 Hall BM. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell. J Exp Med 1985; 161: 123–33. 136 Hutchinson IV. Suppressor T cells in allogeneic models. Transplantation 1986; 41: 547–55. 137 Goulmy E, Persijn G, Blokland E, D'Amaro J, van Rood JJ. Cell-mediated lympholysis studies in renal allograft recipients. Transplantation 1981; 31: 210–7. 138 Thomas J, Thomas F, Mendez-Picon G, Lee H. Immunological monitoring of long-surviving renal transplant recipients. Surgery 1977; 81: 125–31. 139 Fischer E, Lenhard V, Seifert P, Kluge A, Johannsen R. Blood transfusion-induced suppression of cellular immunity in man. Hum Immunol 1980; 3: 187–94. 140 Russ GR, Miach P, D'Apice A, Kincaid-Smith P. Dinitrochlo-robenzene skin testing: correlation with graft survival and effect of blood transfusion. Transplant Proc 1984; 16: 998–9. 141 Jeannet M, Neri-Legendre C, Descoeudres C, Leski M. Does blood transfusion induce a nonspecific suppression of cell-mediated immunity? Transplant Proc 1982; 14: 325–8. 142 Jeffery JR, Cheung K, Masniuk J, Taylor D. Mixed lymphocyte culture responses Lack of correlation with cadaveric renal allograft survival and blood transfusions. Transplantation 1984; 38: 42–5. 143 Leivestad T, Thorsby E. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness. Transplantation 1984; 37: 175–81. 144 Andersson LC, Binz H, Wigzell H. Specific unresponsiveness to transplantation antigens induced by auto-immunisation with syngeneic, antigen-specific T lymphoblasts. Nature 1976; 264: 778–80. 145 Binz H, Wigzell H. Shared idiotypic determinants on B and T lymphocytes reactive against the same antigenic determinants. I. Demonstration of similar or identical idiotypes on IgG molecules and T-cell receptors with specificity for the same alloantigens. J Exp Med 1975; 142: 197–211. 146 Binz H, Wigzell H. Successful induction of specific tolerance to transplantation antigens using autoimmunisation against the recipients own natural antibodies. Nature 1976; 262: 294–5. 147 Myburgh JA, Smit JA. Autoantiidiotypic immunization and transplantation tolerance in the primate. Transplant Proc 1979; 11: 923–7. 148 Strong DM, Ahmed A, Leapman SB, et al. Induction of memory cells in vitro with an antiidiotype serum against the recognition structure specific for cells primed for histocompatiblity determinants. Transplant Proc 1979; 11: 928–31. 149 Auchincloss H Jr, Bluestone JA, Sachs DH. Antiidiotypes against anti-H-2 monoclonal antibodies. V. In vivo antiidiotype treatment induces idiotype-specific helper T cells. J Exp Med 1983; 157: 1273–85. 150 Bluestone JA, Epstein SL, Ozato K, Sharrow SO, Sachs DH. Anti-idiotypes to monoclonal anti-H-2 antibodies. II. Expression of anti-H-2Kk idiotypes on antibodies induced by anti-idiotype or H-2Kk antigen. J Exp Med 1981; 154: 1305–17. 151 Sachs DH, Bluestone JA, Epstein SL, Ozato K. Antiidiotypes to monoclonal anti-H-2 and anti-Ia hybridoma antibodies. Transplant Proc 1981; 13: 953–7. 152 Brouet JC, Dellagi K, Gendron MC, Chevalier A, Schmitt C, Mihaesco E. Expression of a public idiotype by human monoclonal IgM directed to myelin-associated glycoprotein and characterization of the variability subgroup of their heavy and light chains. J Exp Med 1989; 170: 1551–8. 153 Nagarkatti PS, Joseph S, Singal DP. Induction of antibodies by blood transfusions capable of inhibiting responses in MLC. Transplantation 1983; 36: 695–9. 154 Downey WE, Baldwin WM, Sanfilippo F. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses. Transplantation 1990; 49: 160–6. 155 Stevenson GT, Elliott EV, Stevenson FK. Idiotypic determinants on the surface immunoglobulin of neoplastic lymphocytes: a therapeutic target. Fed Proc 1977; 36: 2268–71. 156 Haughton G, Lanier LL, Babcock GF, Lynes MA. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen. J Immunol 1978; 121: 2358–62. 157 Stevenson GT, Glennie MJ. Surface immunoglobulin of B-rymphocytic tumours as a therapeutic target. Cancer Surv 1985; 4: 213–44. 158 Hamblin TJ, Abdul-Ahad AK, Gordon J, Stevenson FK, Stevenson GT. Preliminary experience in treating lymphocytic leukaemia with antibody to immunoglobulin idiotypes on the cell surfaces. Br J Cancer 1980; 42: 495–502. 159 Meeker TC, Lowder J, Maloney DG, et al. A clinical trial of antiidiotype therapy for B cell malignancy. Blood 1985; 65: 1349–63. 160 Lowder JN, Meeker TC, Campbell M, et al. Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses. Blood 1987; 69: 199–210. 161 Kipps TJ, Fong S, Tomhave E, Chen PP, Goldfien RD, Carson DA. High-frequency expression of a conserved kappa light-chain variable-region gene in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 1987; 84: 2916–20. 162 Kipps TJ, Robbins BA, Kuster P, Carson DA. Autoantibody-associated cross-reactive idiotypes expressed at high frequency in chronic lymphocytic leukemia relative to B-cell lymphomas of follicular center cell origin. Blood 1988; 72: 422–8. 163 Miller RA, Hart S, Samoszuk M, et al. Shared idiotypes expressed by human B-cell lymphomas. N Engl J Med 1989; 321: 851–7. 164 Chatterjee M, Barcos M, Han T, Liu XL, Bernstein Z, Foon KA. Shared idiotype expression by chronic lymphocytic leukemia and B-cell lymphoma. Blood 1990; 76: 1825–9. 165 Brown SL, Miller RA, Horning SJ, et al. Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 1989; 73: 651–61. 166 Stevenson FK, Gordon J. Immunization with idiotypic immunoglobulin protects against development of B lymphocytic leukemia, but emerging tumor cells can evade antibody attack by modulation. J Immunol 1983; 130: 970–3. 167 Meeker T, Lowder J, Cleary ML, et al. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies. N Engl J Med 1985; 312: 1658–65. 168 Ward RE, McNamara-Ward M, Webb CF, et al. Regulation of an idiotype + B cell lymphoma Effects of antigen and anti-idiotopic antibodies on proliferation and Ig secretion. J Immunol 1988; 141: 340–6. 169 Krolick KA, Uhr JW, Slavin S, Vitetta ES. In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. J Exp Med 1982; 155: 1797–809. 170 Gregg EO, Bridges SH, Youle RJ, et al. Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia. J Immunol 1987; 138: 4502–8. 171 Kohler H, Bona C. Idiotype vaccines. Int Rev Immunol 1986; 1: 1–90. 172 Eichmann K, Emmrich F, Kaufmann SH. Idiotypic vaccinations: consideration towards a practical application. Crit Rev Immunol 1987; 7: 193–227. 173 Kennedy RC, Eichberg JW, Lanford RE, Dreesman GR. Antiidiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science 1986; 232: 220–3. Citing Literature Volume32, Issue4May 1992Pages 361-376 ReferencesRelatedInformation
Referência(s)